{"ticker": {"uuid": "94c5ec44-ab1b-4064-8b18-a1d2acbafdd7", "symbol": "COCH", "name": "Envoy Medical Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRnctYlg4eEVRcEdZSEdjWllPc2tMdFhkZFh5REpkbTlIYXprRHJCbHhNUkVhVGg5d3A2RXNMZUprMjZWdmFOU0UzMzhUZlFKQjh6MmtjWmJLMmZlbHhIdWlyVjJnRkViRnJMSVRVX0JkeWZManBjMFhHMmNZUkQweEpCUDRfYy04RFF5RzZuVUlPcjJfTEVWdVpLX3NObG1UdlRZWDBBQVNvYXB1Umw1VTBOZmlpSVVxVUtkb3RCbFBZbjdsUE5qQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T13:10:03+00:00", "published_display": "21 Jul 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/exclusive-envoy-medical-hits-key-130022073.html", "source_name": "Benzinga", "published_at": "2026-07-21T13:00:22+00:00", "published_display": "21 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial", "summary": "Envoy Medical Inc. announced that all 56 patients in its pivotal clinical trial for the investigational fully implanted Acclaim\u00ae cochlear implant have surpassed the three-month visit milestone. This achievement brings the company closer to submitting its Premarket Approval applic", "url": "https://www.newsfilecorp.com/release/305827/Envoy-Medical-Surpasses-ThreeMonth-Visit-Milestone-for-All-56-Patients-in-Pivotal-Clinical-Trial", "source_name": "TMX Newsfile", "published_at": "2026-07-21T13:41:12", "published_display": "21 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All 56 patients reach 3 months in Envoy Medical's hearing implant trial", "summary": "Envoy Medical (NASDAQ: COCH) announced that all 56 patients in its pivotal clinical trial for the investigational Acclaim cochlear implant have completed their three-month visit milestone. This achievement is a crucial step toward the company's planned Premarket Approval (PMA) su", "url": "https://www.stocktitan.net/news/COCH/envoy-medical-surpasses-three-month-visit-milestone-for-all-56-7k106iudfaex.html", "source_name": "Stock Titan", "published_at": "2026-07-21T13:41:12", "published_display": "21 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOcXdEazAwSXc0MXFRRF90eVQ5Z3NBVnZzcGxzT1FvWlBXX1RXR0loeTh1ZXBtUl96Rk15Sm1ocUl5azNzZ01adE12aFNLU3Jyd1hIOUZsd21tcTBSLVd6NjF3NzJZcTAyVDNmTTZtTHVKdUZtRTV1Y0loekotUXBtZ3dtQlZyRS05cWQyclRqN2FBMDV3Mmk1VGJnSVpldE85WFprdWQ5SUs0VGlETU9oNDd3aUdPeEMtclJqMWVTRG1LNjV1Tmc?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T02:00:37+00:00", "published_display": "21 Jul 2026 02:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results", "summary": "Envoy Medical Inc. reported improved 12-month results from Stage 1 of its pivotal clinical trial for the Acclaim cochlear implant, showing a significant increase in hearing performance compared to baseline and six-month data. Participants achieved a mean CNC word recognition scor", "url": "https://www.sahmcapital.com/news/content/exclusive-envoy-medical-builds-momentum-with-improved-cochlear-implant-trial-results-2026-07-14", "source_name": "Sahm", "published_at": "2026-07-16T03:41:44", "published_display": "16 Jul 2026 03:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright reiterates Envoy Medical stock rating on trial progress By Investing.com", "summary": "H.C. Wainwright has reiterated a Buy rating and a $2.50 price target for Envoy Medical (NASDAQ:COCH) after an update on the pivotal trial of its Acclaim cochlear implant. The company announced that the first three patients have completed their 12-month endpoint visits, with topli", "url": "https://m.za.investing.com/news/stock-market-news/hc-wainwright-reiterates-envoy-medical-stock-rating-on-trial-progress-93CH-4370227?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-15T15:40:11", "published_display": "15 Jul 2026 15:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant", "summary": "Envoy Medical announced positive 12-month data from Stage 1 of its pivotal clinical trial for the Acclaim\u00ae fully implanted cochlear implant, showing significant improvements in speech perception. The study's first 10 participants demonstrated a substantial increase in CNC word re", "url": "https://finance.yahoo.com/healthcare/articles/envoy-medical-reports-positive-12-131700768.html", "source_name": "Market source", "published_at": "2026-07-15T04:40:24", "published_display": "15 Jul 2026 04:40", "sentiment": "positive", "sentiment_pct": 87, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical submits first module of PMA to FDA for implant", "summary": "Envoy Medical Inc. (NASDAQ:COCH) has submitted the first module of its Modular Premarket Approval (PMA) application to the FDA for its Acclaim cochlear implant, which has Breakthrough Device Designation. The company plans to submit a total of four modules, with clinical data expe", "url": "https://m.uk.investing.com/news/stock-market-news/envoy-medical-submits-first-module-of-pma-to-fda-for-implant-93CH-4750658?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-01T12:10:20", "published_display": "01 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insiders Of Envoy Medical Are Up 98% On Their US$8.17m Purchase", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical starts FDA review of its breakthrough hearing device", "summary": "Envoy Medical (NASDAQ: COCH) has submitted the first module of its modular Premarket Approval (PMA) application to the FDA for its Breakthrough Device-designated Acclaim cochlear implant. This marks the initial step in a four-module strategy, with the final clinical module expect", "url": "https://www.stocktitan.net/news/COCH/envoy-medical-submits-first-module-of-modular-premarket-approval-6tyb76xrq6tu.html", "source_name": "Stock Titan", "published_at": "2026-07-01T00:12:50", "published_display": "01 Jul 2026 00:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) terminates $15 million ATM equity facility", "summary": "Envoy Medical, Inc. (NASDAQ: COCH) has terminated its $15 million at-the-market (ATM) equity facility, effective June 24, 2026. This decision, which also ends the related At The Market Offering Agreement, reflects the company's confidence in its current capital position. The comp", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-702f6ace8ec7.html", "source_name": "Stock Titan", "published_at": "2026-06-30T20:10:42", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device", "summary": "Envoy Medical Inc. has submitted the first module of its Modular Premarket Approval (PMA) application to the FDA for its Breakthrough Device-designated hearing solution. This modular approach allows for earlier FDA engagement and feedback, reducing regulatory risk and providing c", "url": "https://www.newsfilecorp.com/release/303387/Envoy-Medical-Submits-First-Module-of-Modular-Premarket-Approval-Application-to-the-U.S.-Food-and-Drug-Administration-for-BreakthroughDesignated-Device", "source_name": "TMX Newsfile", "published_at": "2026-06-30T08:30:00", "published_display": "30 Jun 2026 08:30", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (Nasdaq:COCH) - Stock Analysis", "summary": "Envoy Medical (Nasdaq:COCH) is a hearing health company with a market cap of US$60.9m. The company faces significant risks including shareholder dilution, declining earnings, low revenue, negative equity, and issues with Nasdaq's listing requirements. Despite some positive earnin", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-coch/envoy-medical", "source_name": "Simply Wall Street", "published_at": "2026-06-29T22:40:23", "published_display": "29 Jun 2026 22:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical terminates $15 million equity offering facility", "summary": "Envoy Medical Inc. (NASDAQ:COCH) has terminated its at-the-market equity facility, which allowed it to sell up to $15 million in common stock, effective June 24, 2026. The company\u2019s shares are currently trading at $0.63, a 56% decrease over the past year, with a market cap of $48", "url": "https://www.investing.com/news/company-news/envoy-medical-terminates-15-million-equity-offering-facility-93CH-4760644", "source_name": "Investing.com", "published_at": "2026-06-28T14:11:17", "published_display": "28 Jun 2026 14:11", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Envoy Medical Inc For: 23 June By Investing.com", "summary": "This article announces the filing of a Form 4 by Envoy Medical Inc. for June 23rd. Form 4 is a U.S. Securities and Exchange Commission (SEC) document that must be filed by company insiders to report changes in their beneficial ownership of the company's securities. The brief noti", "url": "https://uk.investing.com/news/stock-market-news/form-4-envoy-medical-inc-for-23-june-93CH-4741432", "source_name": "Investing.com UK", "published_at": "2026-06-26T23:40:19", "published_display": "26 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Terminates At-the-Market (ATM) Equity Facility", "summary": "Envoy Medical, Inc. (NASDAQ: COCH) has announced the formal termination of its at-the-market (ATM) equity facility, effective June 24, 2026. This decision reflects the company's confidence in its current capital position. Envoy Medical focuses on pioneering fully implanted hearin", "url": "https://www.newsfilecorp.com/release/302819/Envoy-Medical-Terminates-AttheMarket-ATM-Equity-Facility", "source_name": "TMX Newsfile", "published_at": "2026-06-26T10:39:24", "published_display": "26 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical, Inc. Class A Actuals & Estimates (BOATS:COCH)", "summary": "This article provides financial actuals and estimates for Envoy Medical, Inc. (BOATS:COCH). It details the company's income statement, balance sheet, cash flow, and valuation metrics, while also addressing frequently asked questions about its stock performance, earnings, revenue,", "url": "https://www.tradingview.com/symbols/BOATS-COCH/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:10:29", "published_display": "25 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) ties major CEO RSU grant to FDA approval", "summary": "Envoy Medical (NASDAQ: COCH) has updated CEO Brent Lucas's compensation package, including a new base salary of $420,000 and a potential $105,000 cash bonus tied to strategic goals. A significant portion of this revised compensation involves equity awards: 1,000,000 stock options", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-d3f93d7962c7.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:10:29", "published_display": "25 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical shuts down its $15M stock-sale facility", "summary": "Envoy Medical (NASDAQ: COCH) has terminated its at-the-market (ATM) equity facility, which previously allowed the company to sell up to $15 million in common stock. The termination, effective June 24, 2026, reflects the company's confidence in its current capital position. Follow", "url": "https://www.stocktitan.net/news/COCH/envoy-medical-terminates-at-the-market-atm-equity-b0931l2xcxkl.html", "source_name": "Stock Titan", "published_at": "2026-06-25T12:41:27", "published_display": "25 Jun 2026 12:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical terminates $15 million equity offering facility By Investing.com", "summary": "Envoy Medical, Inc. has terminated its $15 million at-the-market equity facility, effective June 24, 2026. This facility allowed the company to offer and sell shares of its common stock. Despite the termination, the company, which develops fully implanted hearing solutions, conti", "url": "https://ca.investing.com/news/stock-market-news/envoy-medical-terminates-15-million-equity-offering-facility-93CH-4707557", "source_name": "Investing.com Canada", "published_at": "2026-06-25T12:41:27", "published_display": "25 Jun 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical to Present at Investor Conferences on June 25th", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/envoy-medical-present-investor-conferences-123000976.html", "source_name": "TMX Newsfile", "published_at": "2026-06-18T12:30:00+00:00", "published_display": "18 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical, Inc. Class A Financial Disclosures & SEC Filings", "summary": "This article provides an overview of Envoy Medical, Inc. Class A's financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K. It lists earnings reports from Q1 FY2025 to Q1 FY2026, highlighting key operational updates, clinical trial progress, and financial perfo", "url": "https://www.tradingview.com/symbols/NASDAQ-COCH/documents/", "source_name": "TradingView", "published_at": "2026-06-13T00:39:25", "published_display": "13 Jun 2026 00:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Highlights: CooperCompanies (NASDAQ:COO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNN1hOQW5NYmtjUWRLcFdNUmFSOEtxN1NEUHVZdmVCaW5nRGdlYjFxbEJySFVRczltT1BYQkR6clNNYUFuRE9mTllDLUtSUE9RUzZfbVktdnFKUU5oVFJnYktGbWlSUEZwS3lYejl4Mkp2VDBZMFRFOUNsdmZhLUxfZXdLTU01N3VIMlBNM1Y3Ym13LWhlY0lJTmFQUXlockRjUk16alFtblpXV2VITkpOOUdn?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQWlEweko5d2hyZUFhUjRsYU1QcElacmR0UktDcFZGUmFXSHpGN05OLV9tYS1VRTlfTHpGRXEzNi12cXZlcTJYVDhZRTZnWG1DUEVFT3hxMG5RcUpORUsyQWN3VVY0eENoZnFMYkdLOXk1Y2d5SFluWDBZU2ZsUl90cHZWY2pKQXZwS212WkcxejJjQ3hlYmtqMFRhWm1neHVYRDZvUzFtVmM4dXVY?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Granted Extension to Regain Nasdaq Compliance", "summary": "Envoy Medical (COCH) has received a second 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, pushing the deadline to November 16, 2026. The company had failed to meet the requirement for 30 consecutive business days, and while it mee", "url": "https://www.theglobeandmail.com/investing/markets/stocks/COCH-Q/pressreleases/2104464/envoy-medical-granted-extension-to-regain-nasdaq-compliance/", "source_name": "The Globe and Mail", "published_at": "2026-05-24T08:10:21", "published_display": "24 May 2026 08:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule", "summary": "Envoy Medical (NASDAQ: COCH) has received an additional 180-day extension from Nasdaq, until November 16, 2026, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock had previously traded below $1.00 for 30 consecutive business days", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-659443c1c685.html", "source_name": "Stock Titan", "published_at": "2026-05-22T20:10:52", "published_display": "22 May 2026 20:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology", "summary": "Envoy Medical Inc. (NASDAQ: COCH) has significantly expanded its intellectual property portfolio with the issuance of multiple patents in Australia and Europe, alongside an upcoming European patent grant. These patents focus on fully implanted hearing technology, covering innovat", "url": "https://www.newsfilecorp.com/release/298064/Envoy-Medical-Announces-New-Patents-Expanding-Intellectual-Property-Portfolio-in-Fully-Implanted-Hearing-Technology", "source_name": "TMX Newsfile", "published_at": "2026-05-21T11:08:51", "published_display": "21 May 2026 11:08", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical shareholders approve plan amendments and board elections at annual meeting", "summary": "Envoy Medical shareholders approved amendments to the company's 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan, authorizing additional shares. They also elected Brent T. Lucas and Susan J. Kantor to the board, ratified EisnerAmper, LLP as the independent account", "url": "https://m.investing.com/news/sec-filings/envoy-medical-shareholders-approve-plan-amendments-and-board-elections-at-annual-meeting-93CH-4696851?ampMode=1", "source_name": "Investing.com", "published_at": "2026-05-18T20:40:05", "published_display": "18 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans", "summary": "Envoy Medical, Inc. (NASDAQ: COCH) stockholders approved significant amendments to the company's 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan at their 2026 Annual Meeting. These amendments authorize an additional 6,000,000 shares for equity awards and 1,200,00", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-a7d190508712.html", "source_name": "Stock Titan", "published_at": "2026-05-18T19:40:05", "published_display": "18 May 2026 19:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Reports Full Year 2025 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOdGx1d3U0RElMd2Rub21HWDRSWFpwOW9uejdVZzU1MEZUM2VLbnZNemc2MzJYaTBxV3ZWVkptbnJGdlBaU091cS0tWk1qTUo2bmFuOUx5dm4xZm9DN2lUamRZRFU4WUhmTFZDcDV4eU5sRW0yQmF2X0xXZkFPaUt4aFQ4VUFNOWs1MzdkRXFkdjRtY09VblpZV052eUhrSVk?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQZXhDWktWZlhhSHlxNVZrNWllaDhhWlNXZmhKYlQ4ODRJMHozNTR2TVVKSWVrQV94bzNNU0hfVW5qODRlWW01anFmTG5SYmZoUlJpU09UbkpSemxVbHRGb1F1MGVvZFdqSEVBcUZ5Ti1ZVHlzY3pZYTdCS21RcDJPTnppdWRKVlZjd2ZUeA?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxNYzNMMXQ4cmZOa0xGN2pNZjFrQnN2MWc0dGNWTnhqMEp5UzZQVWViVkx6TWM3Q3Nldk8yOHZVUW5uNUN0MnBaX0RZT3AwZm5KcVR1UVlKZlp0ekN6aVJZam5TTGVwNndzMW12aVljbHlxQ1dWbHBLS1BUSnF3NjMyZWpTbnZHT1Q1dHR5OEhZTlFpRENqbG9nZVQ0ZWlTaHR6b2N2WlpMakdzY25yVEFPZlZCWTd2N2VZa1A1R1FZck9Ta2hoeXZLeGctUTV3N0g0cE52cmxiOGMxUXJQZ29YdVVUc1VoNFBBNG9BRWtR?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxOVmxzVmktRUUzUEllZ1JmV1ZFdS1BbGxhQzdEWVZUX3JlLWY5emt3VVl5TWZST3hueVNlNk9GR2pWSUgwQkIwdDhwUHJqUEgwTC1SRHdMeFpmeXNTRkZva1M2c0ZOSGF2TjlscUpwYW1HVkkxOXBFSVplSXJzS3dsZHBMRjhwMXNQSTBKMDB3TUpjUWJRRWMyTTJNQXBOaXFxUVlqNkVaeTQ3Y2ltVUkyN3hJMzdDNjBMN2pYbkoyNzF3T0I1TkdfRmtZMGRSN2l2R1ptUUdrSXBGZmZGTFZ3cWNzVkowTGhTajJGV0NES1Bxdw?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-10-09T20:07:24+00:00", "published_display": "09 Oct 2025 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQMEgtcFplT2t3UlV0TVJSbkFMN1JkZTlZOEsxQ2VRdEFyZkRFcC1taW9ZVUZhUnZxUnY4OVpXM0ZGYmVpRVNlU3oyc2NyaU9QcmZhNVFxNkpYdllLZXp1VlJMUFR5V3FPZmZ4OWdRRnl1dW1mZEhWNlNPWkkxY3NUNEZfeVhkYk9HRGc?oc=5", "source_name": "Market source", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRnctYlg4eEVRcEdZSEdjWllPc2tMdFhkZFh5REpkbTlIYXprRHJCbHhNUkVhVGg5d3A2RXNMZUprMjZWdmFOU0UzMzhUZlFKQjh6MmtjWmJLMmZlbHhIdWlyVjJnRkViRnJMSVRVX0JkeWZManBjMFhHMmNZUkQweEpCUDRfYy04RFF5RzZuVUlPcjJfTEVWdVpLX3NObG1UdlRZWDBBQVNvYXB1Umw1VTBOZmlpSVVxVUtkb3RCbFBZbjdsUE5qQQ?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T13:10:03+00:00", "published_display": "21 Jul 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/exclusive-envoy-medical-hits-key-130022073.html", "source_name": "Benzinga", "published_at": "2026-07-21T13:00:22+00:00", "published_display": "21 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial", "summary": "Envoy Medical Inc. announced that all 56 patients in its pivotal clinical trial for the investigational fully implanted Acclaim\u00ae cochlear implant have surpassed the three-month visit milestone. This achievement brings the company closer to submitting its Premarket Approval applic", "url": "https://www.newsfilecorp.com/release/305827/Envoy-Medical-Surpasses-ThreeMonth-Visit-Milestone-for-All-56-Patients-in-Pivotal-Clinical-Trial", "source_name": "TMX Newsfile", "published_at": "2026-07-21T13:41:12", "published_display": "21 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All 56 patients reach 3 months in Envoy Medical's hearing implant trial", "summary": "Envoy Medical (NASDAQ: COCH) announced that all 56 patients in its pivotal clinical trial for the investigational Acclaim cochlear implant have completed their three-month visit milestone. This achievement is a crucial step toward the company's planned Premarket Approval (PMA) su", "url": "https://www.stocktitan.net/news/COCH/envoy-medical-surpasses-three-month-visit-milestone-for-all-56-7k106iudfaex.html", "source_name": "Stock Titan", "published_at": "2026-07-21T13:41:12", "published_display": "21 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOcXdEazAwSXc0MXFRRF90eVQ5Z3NBVnZzcGxzT1FvWlBXX1RXR0loeTh1ZXBtUl96Rk15Sm1ocUl5azNzZ01adE12aFNLU3Jyd1hIOUZsd21tcTBSLVd6NjF3NzJZcTAyVDNmTTZtTHVKdUZtRTV1Y0loekotUXBtZ3dtQlZyRS05cWQyclRqN2FBMDV3Mmk1VGJnSVpldE85WFprdWQ5SUs0VGlETU9oNDd3aUdPeEMtclJqMWVTRG1LNjV1Tmc?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T02:00:37+00:00", "published_display": "21 Jul 2026 02:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results", "summary": "Envoy Medical Inc. reported improved 12-month results from Stage 1 of its pivotal clinical trial for the Acclaim cochlear implant, showing a significant increase in hearing performance compared to baseline and six-month data. Participants achieved a mean CNC word recognition scor", "url": "https://www.sahmcapital.com/news/content/exclusive-envoy-medical-builds-momentum-with-improved-cochlear-implant-trial-results-2026-07-14", "source_name": "Sahm", "published_at": "2026-07-16T03:41:44", "published_display": "16 Jul 2026 03:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright reiterates Envoy Medical stock rating on trial progress By Investing.com", "summary": "H.C. Wainwright has reiterated a Buy rating and a $2.50 price target for Envoy Medical (NASDAQ:COCH) after an update on the pivotal trial of its Acclaim cochlear implant. The company announced that the first three patients have completed their 12-month endpoint visits, with topli", "url": "https://m.za.investing.com/news/stock-market-news/hc-wainwright-reiterates-envoy-medical-stock-rating-on-trial-progress-93CH-4370227?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-15T15:40:11", "published_display": "15 Jul 2026 15:40", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant", "summary": "Envoy Medical announced positive 12-month data from Stage 1 of its pivotal clinical trial for the Acclaim\u00ae fully implanted cochlear implant, showing significant improvements in speech perception. The study's first 10 participants demonstrated a substantial increase in CNC word re", "url": "https://finance.yahoo.com/healthcare/articles/envoy-medical-reports-positive-12-131700768.html", "source_name": "Market source", "published_at": "2026-07-15T04:40:24", "published_display": "15 Jul 2026 04:40", "sentiment": "positive", "sentiment_pct": 87, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical submits first module of PMA to FDA for implant", "summary": "Envoy Medical Inc. (NASDAQ:COCH) has submitted the first module of its Modular Premarket Approval (PMA) application to the FDA for its Acclaim cochlear implant, which has Breakthrough Device Designation. The company plans to submit a total of four modules, with clinical data expe", "url": "https://m.uk.investing.com/news/stock-market-news/envoy-medical-submits-first-module-of-pma-to-fda-for-implant-93CH-4750658?ampMode=1", "source_name": "Investing.com", "published_at": "2026-07-01T12:10:20", "published_display": "01 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insiders Of Envoy Medical Are Up 98% On Their US$8.17m Purchase", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical starts FDA review of its breakthrough hearing device", "summary": "Envoy Medical (NASDAQ: COCH) has submitted the first module of its modular Premarket Approval (PMA) application to the FDA for its Breakthrough Device-designated Acclaim cochlear implant. This marks the initial step in a four-module strategy, with the final clinical module expect", "url": "https://www.stocktitan.net/news/COCH/envoy-medical-submits-first-module-of-modular-premarket-approval-6tyb76xrq6tu.html", "source_name": "Stock Titan", "published_at": "2026-07-01T00:12:50", "published_display": "01 Jul 2026 00:12", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) terminates $15 million ATM equity facility", "summary": "Envoy Medical, Inc. (NASDAQ: COCH) has terminated its $15 million at-the-market (ATM) equity facility, effective June 24, 2026. This decision, which also ends the related At The Market Offering Agreement, reflects the company's confidence in its current capital position. The comp", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-702f6ace8ec7.html", "source_name": "Stock Titan", "published_at": "2026-06-30T20:10:42", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device", "summary": "Envoy Medical Inc. has submitted the first module of its Modular Premarket Approval (PMA) application to the FDA for its Breakthrough Device-designated hearing solution. This modular approach allows for earlier FDA engagement and feedback, reducing regulatory risk and providing c", "url": "https://www.newsfilecorp.com/release/303387/Envoy-Medical-Submits-First-Module-of-Modular-Premarket-Approval-Application-to-the-U.S.-Food-and-Drug-Administration-for-BreakthroughDesignated-Device", "source_name": "TMX Newsfile", "published_at": "2026-06-30T08:30:00", "published_display": "30 Jun 2026 08:30", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (Nasdaq:COCH) - Stock Analysis", "summary": "Envoy Medical (Nasdaq:COCH) is a hearing health company with a market cap of US$60.9m. The company faces significant risks including shareholder dilution, declining earnings, low revenue, negative equity, and issues with Nasdaq's listing requirements. Despite some positive earnin", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-coch/envoy-medical", "source_name": "Simply Wall Street", "published_at": "2026-06-29T22:40:23", "published_display": "29 Jun 2026 22:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical terminates $15 million equity offering facility", "summary": "Envoy Medical Inc. (NASDAQ:COCH) has terminated its at-the-market equity facility, which allowed it to sell up to $15 million in common stock, effective June 24, 2026. The company\u2019s shares are currently trading at $0.63, a 56% decrease over the past year, with a market cap of $48", "url": "https://www.investing.com/news/company-news/envoy-medical-terminates-15-million-equity-offering-facility-93CH-4760644", "source_name": "Investing.com", "published_at": "2026-06-28T14:11:17", "published_display": "28 Jun 2026 14:11", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Envoy Medical Inc For: 23 June By Investing.com", "summary": "This article announces the filing of a Form 4 by Envoy Medical Inc. for June 23rd. Form 4 is a U.S. Securities and Exchange Commission (SEC) document that must be filed by company insiders to report changes in their beneficial ownership of the company's securities. The brief noti", "url": "https://uk.investing.com/news/stock-market-news/form-4-envoy-medical-inc-for-23-june-93CH-4741432", "source_name": "Investing.com UK", "published_at": "2026-06-26T23:40:19", "published_display": "26 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Terminates At-the-Market (ATM) Equity Facility", "summary": "Envoy Medical, Inc. (NASDAQ: COCH) has announced the formal termination of its at-the-market (ATM) equity facility, effective June 24, 2026. This decision reflects the company's confidence in its current capital position. Envoy Medical focuses on pioneering fully implanted hearin", "url": "https://www.newsfilecorp.com/release/302819/Envoy-Medical-Terminates-AttheMarket-ATM-Equity-Facility", "source_name": "TMX Newsfile", "published_at": "2026-06-26T10:39:24", "published_display": "26 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical, Inc. Class A Actuals & Estimates (BOATS:COCH)", "summary": "This article provides financial actuals and estimates for Envoy Medical, Inc. (BOATS:COCH). It details the company's income statement, balance sheet, cash flow, and valuation metrics, while also addressing frequently asked questions about its stock performance, earnings, revenue,", "url": "https://www.tradingview.com/symbols/BOATS-COCH/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T21:10:29", "published_display": "25 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) ties major CEO RSU grant to FDA approval", "summary": "Envoy Medical (NASDAQ: COCH) has updated CEO Brent Lucas's compensation package, including a new base salary of $420,000 and a potential $105,000 cash bonus tied to strategic goals. A significant portion of this revised compensation involves equity awards: 1,000,000 stock options", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-d3f93d7962c7.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:10:29", "published_display": "25 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical shuts down its $15M stock-sale facility", "summary": "Envoy Medical (NASDAQ: COCH) has terminated its at-the-market (ATM) equity facility, which previously allowed the company to sell up to $15 million in common stock. The termination, effective June 24, 2026, reflects the company's confidence in its current capital position. Follow", "url": "https://www.stocktitan.net/news/COCH/envoy-medical-terminates-at-the-market-atm-equity-b0931l2xcxkl.html", "source_name": "Stock Titan", "published_at": "2026-06-25T12:41:27", "published_display": "25 Jun 2026 12:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical terminates $15 million equity offering facility By Investing.com", "summary": "Envoy Medical, Inc. has terminated its $15 million at-the-market equity facility, effective June 24, 2026. This facility allowed the company to offer and sell shares of its common stock. Despite the termination, the company, which develops fully implanted hearing solutions, conti", "url": "https://ca.investing.com/news/stock-market-news/envoy-medical-terminates-15-million-equity-offering-facility-93CH-4707557", "source_name": "Investing.com Canada", "published_at": "2026-06-25T12:41:27", "published_display": "25 Jun 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical to Present at Investor Conferences on June 25th", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/envoy-medical-present-investor-conferences-123000976.html", "source_name": "TMX Newsfile", "published_at": "2026-06-18T12:30:00+00:00", "published_display": "18 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical, Inc. Class A Financial Disclosures & SEC Filings", "summary": "This article provides an overview of Envoy Medical, Inc. Class A's financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K. It lists earnings reports from Q1 FY2025 to Q1 FY2026, highlighting key operational updates, clinical trial progress, and financial perfo", "url": "https://www.tradingview.com/symbols/NASDAQ-COCH/documents/", "source_name": "TradingView", "published_at": "2026-06-13T00:39:25", "published_display": "13 Jun 2026 00:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Highlights: CooperCompanies (NASDAQ:COO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNN1hOQW5NYmtjUWRLcFdNUmFSOEtxN1NEUHVZdmVCaW5nRGdlYjFxbEJySFVRczltT1BYQkR6clNNYUFuRE9mTllDLUtSUE9RUzZfbVktdnFKUU5oVFJnYktGbWlSUEZwS3lYejl4Mkp2VDBZMFRFOUNsdmZhLUxfZXdLTU01N3VIMlBNM1Y3Ym13LWhlY0lJTmFQUXlockRjUk16alFtblpXV2VITkpOOUdn?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQWlEweko5d2hyZUFhUjRsYU1QcElacmR0UktDcFZGUmFXSHpGN05OLV9tYS1VRTlfTHpGRXEzNi12cXZlcTJYVDhZRTZnWG1DUEVFT3hxMG5RcUpORUsyQWN3VVY0eENoZnFMYkdLOXk1Y2d5SFluWDBZU2ZsUl90cHZWY2pKQXZwS212WkcxejJjQ3hlYmtqMFRhWm1neHVYRDZvUzFtVmM4dXVY?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Granted Extension to Regain Nasdaq Compliance", "summary": "Envoy Medical (COCH) has received a second 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, pushing the deadline to November 16, 2026. The company had failed to meet the requirement for 30 consecutive business days, and while it mee", "url": "https://www.theglobeandmail.com/investing/markets/stocks/COCH-Q/pressreleases/2104464/envoy-medical-granted-extension-to-regain-nasdaq-compliance/", "source_name": "The Globe and Mail", "published_at": "2026-05-24T08:10:21", "published_display": "24 May 2026 08:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule", "summary": "Envoy Medical (NASDAQ: COCH) has received an additional 180-day extension from Nasdaq, until November 16, 2026, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock had previously traded below $1.00 for 30 consecutive business days", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-659443c1c685.html", "source_name": "Stock Titan", "published_at": "2026-05-22T20:10:52", "published_display": "22 May 2026 20:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology", "summary": "Envoy Medical Inc. (NASDAQ: COCH) has significantly expanded its intellectual property portfolio with the issuance of multiple patents in Australia and Europe, alongside an upcoming European patent grant. These patents focus on fully implanted hearing technology, covering innovat", "url": "https://www.newsfilecorp.com/release/298064/Envoy-Medical-Announces-New-Patents-Expanding-Intellectual-Property-Portfolio-in-Fully-Implanted-Hearing-Technology", "source_name": "TMX Newsfile", "published_at": "2026-05-21T11:08:51", "published_display": "21 May 2026 11:08", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical shareholders approve plan amendments and board elections at annual meeting", "summary": "Envoy Medical shareholders approved amendments to the company's 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan, authorizing additional shares. They also elected Brent T. Lucas and Susan J. Kantor to the board, ratified EisnerAmper, LLP as the independent account", "url": "https://m.investing.com/news/sec-filings/envoy-medical-shareholders-approve-plan-amendments-and-board-elections-at-annual-meeting-93CH-4696851?ampMode=1", "source_name": "Investing.com", "published_at": "2026-05-18T20:40:05", "published_display": "18 May 2026 20:40", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans", "summary": "Envoy Medical, Inc. (NASDAQ: COCH) stockholders approved significant amendments to the company's 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan at their 2026 Annual Meeting. These amendments authorize an additional 6,000,000 shares for equity awards and 1,200,00", "url": "https://www.stocktitan.net/sec-filings/COCH/8-k-envoy-medical-inc-reports-material-event-a7d190508712.html", "source_name": "Stock Titan", "published_at": "2026-05-18T19:40:05", "published_display": "18 May 2026 19:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Reports Full Year 2025 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOdGx1d3U0RElMd2Rub21HWDRSWFpwOW9uejdVZzU1MEZUM2VLbnZNemc2MzJYaTBxV3ZWVkptbnJGdlBaU091cS0tWk1qTUo2bmFuOUx5dm4xZm9DN2lUamRZRFU4WUhmTFZDcDV4eU5sRW0yQmF2X0xXZkFPaUt4aFQ4VUFNOWs1MzdkRXFkdjRtY09VblpZV052eUhrSVk?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQZXhDWktWZlhhSHlxNVZrNWllaDhhWlNXZmhKYlQ4ODRJMHozNTR2TVVKSWVrQV94bzNNU0hfVW5qODRlWW01anFmTG5SYmZoUlJpU09UbkpSemxVbHRGb1F1MGVvZFdqSEVBcUZ5Ti1ZVHlzY3pZYTdCS21RcDJPTnppdWRKVlZjd2ZUeA?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxNYzNMMXQ4cmZOa0xGN2pNZjFrQnN2MWc0dGNWTnhqMEp5UzZQVWViVkx6TWM3Q3Nldk8yOHZVUW5uNUN0MnBaX0RZT3AwZm5KcVR1UVlKZlp0ekN6aVJZam5TTGVwNndzMW12aVljbHlxQ1dWbHBLS1BUSnF3NjMyZWpTbnZHT1Q1dHR5OEhZTlFpRENqbG9nZVQ0ZWlTaHR6b2N2WlpMakdzY25yVEFPZlZCWTd2N2VZa1A1R1FZck9Ta2hoeXZLeGctUTV3N0g0cE52cmxiOGMxUXJQZ29YdVVUc1VoNFBBNG9BRWtR?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxOVmxzVmktRUUzUEllZ1JmV1ZFdS1BbGxhQzdEWVZUX3JlLWY5emt3VVl5TWZST3hueVNlNk9GR2pWSUgwQkIwdDhwUHJqUEgwTC1SRHdMeFpmeXNTRkZva1M2c0ZOSGF2TjlscUpwYW1HVkkxOXBFSVplSXJzS3dsZHBMRjhwMXNQSTBKMDB3TUpjUWJRRWMyTTJNQXBOaXFxUVlqNkVaeTQ3Y2ltVUkyN3hJMzdDNjBMN2pYbkoyNzF3T0I1TkdfRmtZMGRSN2l2R1ptUUdrSXBGZmZGTFZ3cWNzVkowTGhTajJGV0NES1Bxdw?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-10-09T20:07:24+00:00", "published_display": "09 Oct 2025 20:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQMEgtcFplT2t3UlV0TVJSbkFMN1JkZTlZOEsxQ2VRdEFyZkRFcC1taW9ZVUZhUnZxUnY4OVpXM0ZGYmVpRVNlU3oyc2NyaU9QcmZhNVFxNkpYdllLZXp1VlJMUFR5V3FPZmZ4OWdRRnl1dW1mZEhWNlNPWkkxY3NUNEZfeVhkYk9HRGc?oc=5", "source_name": "Market source", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 49, "sentiment_summary": {"positive": 16, "negative": 5, "neutral": 28, "score": 56, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 12.45, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 10.45, "count": 19}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 3.85, "count": 7}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 16, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 0.7, "latest_week": "2026-07-17", "one_week_move": 2.7, "four_week_move": 10.7, "twelve_week_move": 4.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.90128, "market_dynamics_buy_signal": false, "relative_strength": -24.832432, "fair_value_gap": -69.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.789, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.7% over one week, +10.7% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 17}, {"label": "TMX Newsfile", "count": 8}, {"label": "Stock Titan", "count": 7}, {"label": "Investing.com", "count": 3}, {"label": "Ad-hoc-news.de", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "Benzinga", "count": 1}, {"label": "Sahm", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 19}, {"label": "Regulatory and legal", "count": 7}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.7% over one week, +10.7% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum"}], "updated_at": "2026-07-21T21:59:59.819726+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}